Floatz logo

R-Bl-M-04

Lymphoma, High-Grade

Elena N.ParovichnikovaPhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

90 Active assets in the Lymphoma, High-Grade cohort.

Asset / SponsorPhaseRating
Ifosfamide
University of California, Davis
Phase 3BB
ETOPOSIDE
University of Washington
Phase 3BB
PREDNISONE TABLETS
National Cancer Institute (NCI)
Phase 3BB
VINCRISTINE SULFATE
National Cancer Institute (NCI)
Phase 2/3BB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
National Cancer Institute (NCI)
Phase 3BB

View all 50 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →